Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Front Public Health ; 10: 815031, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35211446

RESUMO

Objective: To better understand the potential ongoing effects of the COVID-19 pandemic on U.S. university students' mental health and to generate hypotheses as to how universities may best meet students' mental health needs. Participants: Students at a large public university in the United States. Methods: Students were invited via email to participate in either interviews or focus groups regarding their COVID-19 pandemic experiences, including mental health impacts. Recruitment took place in two waves. Sessions were led by student members of the research team and took place via video conference between December 2020 and June 2021. Interviews were audio-recorded and transcribed via Zoom and manually edited and de-identified by the research team. Interview data were analyzed deductively and inductively using a modified grounded theory approach. Results: A total of 40 undergraduate and graduate students took part in the study. Major themes included: (1) Overall impact of the pandemic on mental health; (2) Sources of pandemic stress/mental health impacts; (3) Subsequent coping strategies; and (4) Suggestions for improving university support for student mental health. Subthemes were identified within each major theme. Students reported substantial anxiety and other mental health impacts and felt improvements in communication and access to mental health resources could better support students. Conclusions: This study provides context for the ways in which the COVID-19 pandemic may be continuing to impact mental health in a north-American university setting and identifies suggestions for potential interventions that future studies may test for effectiveness.


Assuntos
COVID-19 , Universidades , COVID-19/epidemiologia , Humanos , Saúde Mental , Pandemias , SARS-CoV-2 , Estudantes/psicologia , Estados Unidos/epidemiologia
2.
Am J Trop Med Hyg ; 99(1): 17-23, 2018 07.
Artigo em Inglês | MEDLINE | ID: mdl-29761762

RESUMO

Important strides have been made within the past decade toward malaria elimination in many regions, and with this progress, the feasibility of eradication is once again under discussion. If the ambitious goal of eradication is to be achieved by 2040, all species of Plasmodium infecting humans will need to be targeted with evidence-based and concerted interventions. In this perspective, the potential barriers to achieving global malaria elimination are discussed with respect to the related diversities in host, parasite, and vector populations. We argue that control strategies need to be reorientated from a sequential attack on each species, dominated by Plasmodium falciparum to one that targets all species in parallel. A set of research themes is proposed to mitigate the potential setbacks on the pathway to a malaria-free world.


Assuntos
Erradicação de Doenças/métodos , Malária Falciparum/prevenção & controle , Malária Vivax/prevenção & controle , Malária/prevenção & controle , Animais , Anopheles/parasitologia , Antimaláricos/uso terapêutico , Cloroquina/uso terapêutico , Erradicação de Doenças/economia , Interações Hospedeiro-Parasita , Humanos , Malária/tratamento farmacológico , Malária/imunologia , Malária/parasitologia , Malária Falciparum/tratamento farmacológico , Malária Falciparum/imunologia , Malária Falciparum/parasitologia , Malária Vivax/tratamento farmacológico , Malária Vivax/imunologia , Malária Vivax/parasitologia , Mosquitos Vetores/parasitologia , Plasmodium falciparum/efeitos dos fármacos , Plasmodium falciparum/imunologia , Plasmodium falciparum/patogenicidade , Plasmodium knowlesi/efeitos dos fármacos , Plasmodium knowlesi/imunologia , Plasmodium knowlesi/patogenicidade , Plasmodium malariae/efeitos dos fármacos , Plasmodium malariae/imunologia , Plasmodium malariae/patogenicidade , Plasmodium ovale/efeitos dos fármacos , Plasmodium ovale/imunologia , Plasmodium ovale/patogenicidade , Plasmodium vivax/efeitos dos fármacos , Plasmodium vivax/imunologia , Plasmodium vivax/patogenicidade , Primaquina/uso terapêutico
4.
BMC Infect Dis ; 16(1): 512, 2016 Sep 26.
Artigo em Inglês | MEDLINE | ID: mdl-27670906

RESUMO

BACKGROUND: Dengue is endemic throughout Cambodia, a country faced with significant health and economic challenges. We undertook a clinical study at the National Paediatric Hospital in Phnom Penh to evaluate clinical diagnostic parameters for dengue and predictors of disease outcome. METHODS: Between September 2011 and January 2013, all consecutive inpatients aged between 1 and 15 years and presenting with suspected dengue were enrolled. They were clinically assessed using both the 1997 and 2009 WHO dengue classifications. Specimens were collected upon admission and discharge and tested for dengue at Institut Pasteur in Cambodia. RESULTS: A total of 701 patients were screened. Of these, 79 % were dengue-confirmed by laboratory testing, and 21 % tested dengue-negative. A positive tourniquet test, absence of upper respiratory symptoms, leukopenia, thrombocytopenia, and elevated liver transaminases were independent predictors for laboratory-confirmed dengue among the children. The presence of several warning signs on hospital admission was associated with a concurrent laboratory-confirmed diagnosis of severe disease outcome. CONCLUSIONS: The presence of two or more warning signs was associated with a concurrent laboratory-confirmed diagnosis of severe dengue at hospital admission. Thus, a cumulative score combining simple clinical parameters and first-line laboratory findings could be used to accurately predict dengue virus infection in pediatric populations, optimizing triage in settings with limited laboratory resources.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA